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Correspondence Imaging Biomarkers of Aortic DiseaseIncreased Growth Rates With Eccentric Systolic FlowTo the Editor: Is the aortic dilation that is commonly seen with
bicuspid aortic valve (BAV) related to intrinsic aortic wall fragility
or altered systolic hemodynamics? Recent publications on the topic
favor the intrinsic fragility hypothesis. But recent advancements in
imaging show very abnormal systolic flow in the ascending aortas
of patients with BAV (1). We have been following a cohort of such
patients who have eccentric, helical flow as demonstrated by a
cardiac magnetic resonance (CMR) technique for dynamic blood
flow imaging termed 4D Flow. One consequence of this eccentric
flow is focally elevated wall shear stress at the convexity of the
ascending aorta (2). We hypothesize that the degree of eccentric
flow and resultant skewed shear stress directly contribute to the
development of aortic pathology. Others have examined eccen-
tric flow and enlarged aortic dimensions at a single time point
(3), but causality and temporal evaluation have not been
addressed. Here we investigate the relationship between flow
and ascending aortic growth rates in patients with BAV.
Serial magnetic resonance or computed tomography angiogra-
phy studies were retrospectively reviewed in 25 patients evaluated
Figure 1 Normal and Eccentric Flow
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Thirteen patients had BAV (26.5 years of age, 5 female, 3.5  0.7 cm
baseline aortic size), and 12 with tricuspid aortic valve (TAV)
served as controls (30.7 years of age, 3 female, 3.4  0.5 cm
baseline aortic size). The patients with BAV were relatively free of
significant aortic valve disease; only 3 had greater than mild
stenosis and 1 greater than mild insufficiency. None of the patients
with TAV had valve disease. Ascending aortic diameters were
measured at standard levels by 2 blinded reviewers, and the growth
rate of the maximally enlarged segment was determined. Using a
previously described qualitative approach, ascending aortic blood
flow was graded as normal or mildly or markedly eccentric (2). All
TAV controls had normal flow, whereas 10 of the 13 patients
with BAV had abnormal flow (7 markedly eccentric). Normal-
ized flow displacement from the vessel center, a recently
developed parameter to quantify flow eccentricity, was calcu-
lated as well (4). Growth rates for controls and patients with
BAV, and within the BAV group based on the degree of
eccentric flow, were compared with unpaired Student t tests.
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variable using a linear regression model.
The average follow-up was 4.3  2.9 years. The growth rates of
patients with BAV were significantly higher than those of TAV
controls (0.8 0.7 mm/year vs. 0.1 0.2 mm/year, p value 0.004).
Among patients with BAV, those with abnormal flow patterns
demonstrated significantly higher growth rates than those with normal
flow (1.0  0.6 mm/year vs. 0.0  0 mm/year, p value  0.02).
Furthermore, patients with BAV demonstrating markedly eccen-
tric flow exhibited more rapid growth than other patients with
BAV (1.2  0.7 mm/year vs. 0.3  0.4 mm/year, p value  0.02).
Linear regression between normalized flow displacement and
aortic growth rate showed good correlation (r  0.66).
These results suggest that altered systolic hemodynamics in the
ascending aorta related to BAV play a more significant role in
aortic dilation than currently believed. Higher growth rates are
seen in patients with BAV and abnormal flow (Figure 1). Patients
with markedly eccentric flow demonstrate the most rapid growth.
Two such patients in our cohort have since required surgical aortic
repair. Good correlation is found between growth and a quantita-
tive measure of flow eccentricity, normalized flow displacement.
Our results complement recent data from Della Corte et al. (5)
that demonstrate increased growth rates with restrictive leaflet
excursion (a surrogate for flow eccentricity) in patients with BAV
and right-left aortic leaflet fusion.
Imaging biomarkers such as these could be used to identify and
risk-stratify patients in whom clinically significant aortic disease is
likely to develop. We have shown how both qualitative and
quantitative CMR markers of altered hemodynamics correlate
with disease progression. These biomarkers are uniquely assessed
by CMR. A sizable portion of patients with BAV and eccentric
systolic flow do not have any measurable aortic stenosis (2),
including 4 of 10 patients in this study, and thus would not be
identified as at risk of post-stenotic dilation by echocardiography.
Moreover, the 3-dimensional assessment of wall shear stress and
flow displacement that we report is only achieved with multidi-
rectional phase-contrast CMR imaging.
Yet does the correlation that we report imply causation? Are the
alterations in systolic flow that we have linked to increased aortic
growth merely the consequence of dilated aortic geometries? We
think not because we have shown the same altered flow patterns in
normal-sized aortas and have connected unique flow patterns to
different aortic leaflet fusion patterns with BAV (1). The hemo-
dynamic mechanism that we propose for progressive aortic growthwill, of course, need to be validated with larger, prospective studies
that carefully control for confounding variables. But the fact that
hemodynamic biomarkers can be imaged noninvasively and poten-
tially identify aortic disease well before clinical manifestation is an
attractive goal that could meaningfully improve the clinical man-
agement of patients with aortic valve disease. It may also point to
unique, pathologic cellular mechanisms that could be the targets of
new medical therapy.
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